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ABSTRACT 
AIM: To study the immediate effect of flutter on pulmonary function in patients 
with chronic bronchitis. OBJECTIVE: To find out the immediate effect of flutter 
along with conventional physiotherapy on pulmonary function in chronic 
bronchitis patients. STUDY DESIGN: Pre test- Post test experimental study 
design. METHODOLOGY: 30 patients with chronic bronchitis were selected 
through purposive sampling method for the study and were assigned in two groups. 
Group A consisting of 15 patients were treated with conventional physiotherapy 
where as group B consisting of 15 patients were treated with flutter along with 
conventional physiotherapy. OUTCOME MEASURES: Pre- test, post-test 
measurement using computerized pulmonary function test was done. The values of 
FEV1 and MVV were taken. RESULTS: The data were analyzed using paired‘t’ 
test and independent‘t’ test. With paired‘t’ test there is a significant difference in 
FEV1 and MVV values within the pre test and post test values of both the groups. 
But by using independent‘t’ test, the analysis at 5% level of significance denotes 
that there is no significant difference in FEV1 and significant difference in MVV 
between the groups. CONCLUSION: From the results it can be concluded that 
flutter has immediate effect on pulmonary function in chronic bronchitis patients. 
 
 KEYWORDS: 
       COPD- Chronic Obstructive Pulmonary Disease 
       FEV1- Forced Expiratory Volume in 1 second 
       MVV- Maximum Voluntary Ventilation 
       PFT- Pulmonary Function Test  
       CPT- Chest Physical Therapy 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.  INTRODUCTION 
          Chronic Obstructive Pulmonary Disease is one of the leading causes of 
morbidity and mortality. It affects about 4 -10% of the global population.20 World 
Health Organization estimates that COPD causes 4.7 million deaths annually 
which makes it as the  fifth leading cause of global mortality.47                                            
        Global initiative of chronic obstructive lung disease (GOLD) defined 
Chronic Obstructive Pulmonary Disease as “a disease state characterized bronchitis 
is one of the physiological entities comprising COPD”. 16, 17 
                  Chronic bronchitis has been defined as a disorder in which a patient’s 
cough is productive of sputum for 3 months for at least 2 consecutive years34. 
             Smoking is the main cause for chronic bronchitis.41 
                Chronic obstructive lung diseases are characterized by some degree of 
chronic airflow limitation, or increased secretions, bronchospasm, inflammation or 
destruction of the bronchial walls. 
                The increased airflow limitation is not fully reversible. Airflow 
limitation is usually progressive and also associated with an abnormal 
inflammatory response of the lung to the noxious particles or gases”.        
                Airway mucus hyper secretion is a cardinal feature of COPD. Mucus 
hyper secretion is associated with goblet cell hyperplasia and sub mucosal gland 
hypertrophy. 
                 The number of ciliated cells and ciliary length is decreased in patients 
with chronic bronchitis. 
           Coughing is the hallmark symptom of chronic bronchitis. The cough 
begins slowly and worsens insidiously but steadily until there is mucous 
production. 
              The course of chronic bronchitis is characterized by respiratory 
infections during which severe coughing, dyspnea, production of purulent 
secretions and aberration in pulmonary gas exchange may require hospitalization. 
Prolonged expiratory wheezes, and crackles during expiration, cyanosis and 
pulmonary edema are the classical physical features of the patient with chronic 
bronchitis.34 
                  In addition to their chronic disease patients with COPD experience 
regular acute exacerbation. Management given to patients with COPD includes 
medication & Physiotherapy. The main goal of treatment is to maintain bronchial 
hygiene and improve the pulmonary function.   
                   Physical therapy interventions used are breathing exercise, Postural 
drainage, Autogenic drainage, Active cycle of breathing, Chest expansion exercise 
and Relaxation techniques. 
                  The conventional physiotherapy consists of Diaphragmatic breathing 
exercise, Coughing technique, & segmental breathing.14  
                   Flutter is a simple hand held apparatus that promotes the clearance of 
sputum from the lungs. 
                   The flutter as a device to clear mucus is based on its ability to vibrate 
the airways, intermittently increase endobronchial pressure, and accelerate 
expiratory airflow. 
                   The efficacy of the flutter in facilitating mucus clearance in Cystic 
fibrosis has been resorted.24 
                    The purpose of this study is to find the immediate effect of flutter 
device combined with conventional physiotherapy on pulmonary function in 
chronic bronchitis patients. 
 
 
 
 
 
 
 
 
 
 
1.1. NEED FOR THE STUDY 
 
  Secretion removal plays an important role in physiotherapy 
management of COPD. 
  There are various airway clearance techniques like postural drainage, 
autogenic drainage, active cycle of breathing, expiration with glottis open in the 
lateral posture, coughing technique etc. 
  More studies were conducted to compare the combined effect of 
flutter along with other airway clearance techniques on pulmonary function in 
COPD patients. 
  Konstan et al have compared 3 regimens flutter, voluntary coughing 
and postural drainage which included up to 10 positions. Each session lasted for 15 
minutes. He reported that up to 3 regimens more sputum was expectorated with the 
flutter than other.23 
  Ambrosino et al stated that flutter to be as effective as active cycle of 
breathing.2 
  Lindemann compared autogenic drainage with the flutter and 
concluded that both regimens were equally effective, but the flutter was easier to 
teach.25 
  But only fewer studies were conducted to find the immediate effect on 
pulmonary function using flutter alone to mobilize the secretions. 
           The aim of this study is to find the immediate effect of flutter on 
pulmonary function in chronic bronchitis patients. 
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. REVIEW OF LITERATURE 
 
2.1. INTRODUCTION 
                    Chronic obstructive pulmonary disease is one of the common 
respiratory problems & airway secretion is one of the most important components 
of COPD. Epidemiological evidences say that the mortality of COPD is high, with 
an estimated rate of 48 per 10,000 in men & 18.8 per 10,000 in women. COPD 
accounts about 6.4% of all male deaths and 3.9% of all female deaths.  
                    Smoking is the main causative factor the incidence of COPD is more 
in males than females.27 
2.2. PATHOLOGY 
                    According to Bellone A et al Chronic obstructive lung diseases are 
characterized by some degree of chronic airflow limitation, or increased secretions, 
bronchospasm, inflammation or destruction of the bronchial walls. 
                  The increased airflow limitation is not fully reversible. Airflow 
limitation is usually progressive and also associated with an abnormal 
inflammatory response of the lung to the noxious particles or gases”. 5     
                    King M insisted that mucus hyper secretion is associated with goblet 
cell hyperplasia and sub mucosal gland hypertrophy.23 
                       Rubin BK said that the number of ciliated cells and ciliary length is 
decreased in patients with chronic bronchitis.23 
  2.3. CLINICAL FEATURES 
                       Jan Stephen Tecklin highlighted that coughing is the hallmark 
symptom of chronic bronchitis. The cough begins slowly and worsens insidiously 
but steadily until there is mucous production. 
                  The course of chronic bronchitis is characterized by respiratory 
infections during which severe coughing, dyspnea, production of purulent 
secretions and aberration in pulmonary gas exchange may require hospitalization. 
Prolonged expiratory wheezes, and crackles during expiration, cyanosis and 
pulmonary edema are the classical physical features of the patient with chronic 
bronchitis.34 
 
2.4. CHEST PHYSICAL THERAPY 
                      Scott Irwin et al suggested that chronic obstruction of the airways 
can be caused by increased secretions, bronchospasm, inflammation or destruction 
of the bronchial wall or combination of all. There is an interference of the normal 
flow of air within the lungs and some reversibility of the obstructive components 
can be achieved through the use of bronchodilator and chest physical therapy.34 
                     Pryor et al found out that the effectiveness of various physical 
therapy measures for adults in patients with COPD patients.31 
                     Craig L.Scanlan et al stated that chest physical therapy has been 
shown effective in aiding secretion clearance and improving pulmonary function in 
COPD associated with copious sputum production.13 
                     Health care professionals provide pulmonary rehabilitation as a 
preventive health care program which helps to keep people physically, 
psychologically & socially active with the diseases.15 
 
  2.4.1. FLUTTER 
                      Flutter is a device that uses oscillating positive expiratory pressure 
that varies from 10 to 20 cm H2O. The device creates a self regulated oscillating 
positive pressure, due to a steel ball, with oscillation of the airflow.1 
                     Konstan et al [1994] have compared three regimens FLUTTER, 
voluntary coughing and postural drainage which included up to ten positions. Each 
session lasted for 15 minutes. He reported that up to three regimens more sputum 
was expectorated with the flutter than with other. 
                      The average amount of sputum expectorated with the flutter was over 
four times the amount expectorated after conventional postural drainage with 
percussion and vibration.1, 24 
                     Lindemann [1992] compared autogenic drainage with the flutter and 
concluded that both regimens were equally effective, but flutter was easier to 
teach.25  
                     Burioka N, Sugimoto Y et al [1998], concluded that the use of flutter 
was effective in clearing mucus from the airways.7 
                    Chatham et al [1993], told that use of the flutter in airway clearance 
may improve compliance in some patients, especially children.26 
                   Pryor et al [1994], suggested that flutter to be less effective than 
active cycle of breathing (ACBT).32 
                     Smith D.L. and Harrison [1994], conducted prospective randomized 
clinical trial using flutter  as an adjunct to chest physical therapy in cystic fibrosis. 
The result of the study suggested that using flutter as an adjunct to physiotherapy 
had no significant changes in lung function or oxygenation.32 
                    Ambrosino et al [1995], stated that flutter to be as effective as the 
active cycle of breathing.2 
                    Carolyn C.Campo et al [1996] said that flutter appears to be equally 
as effective as CPT when used as bronchial hygiene therapy for the promotion of 
sputum mobilization and improved breath sounds.8 
                  Homnick D.N, Marks M.H, Anderson K [1998],compared the 
efficacy and safety of the flutter device to standard, manual chest physiotherapy in 
hospitalized patients with cystic fibrosis consisting of 22 patients who performed 
flutter 4 times per day. He concluded that flutter appears to be a useful device for 
independent, cost effective and administration.21 
                  Nakamura.S et al [1996], concluded that use of the flutter can increase 
the expectoration of sputum & can relieve related symptoms.29  
                 Van Winden et al [1998] conducted a crossover randomized study 
comparing the effects of flutter and PEP mask physiotherapy on symptoms & lung 
function in children with cystic fibrosis consisting of 22 children who performed 
physiotherapy using either flutter or PEP mask twice a day for 2 weeks. He 
concluded that there was no significant difference found between the two 
techniques.42 
                 Sharon MH et al [2003],  conducted a pilot study comparing the effect 
of postural drainage or flutter device in conjunction with breathing and coughing 
with breathing & coughing alone in improving secretion removal and lung function 
in patients with acute exacerbation of bronchiectasis, suggested that there was no 
difference in sputum production or lung function parameters among the three 
groups.38 
                Raschi S, Andrea Bellone et al [2000], did a prospective randomized 
study on 3 forms of chest physical therapy including postural drainage, flutter & 
ELTGOL. He concluded that all 3 treatments were effective in patients with acute 
exacerbation of chronic bronchitis.5 
                CS Thompson [2002], conducted a randomized cross over study of 
flutter device and the active cycle of breathing technique in non-cystic fibrosis, 
bronchiectasis and has concluded that both techniques were equally effective.39   
                 He stated that daily use of the flutter device in the home is an effective 
as ACBT in patients with non- cystic fibrosis, bronchiectasis & high level of 
patient acceptability.39 
                Weiner P et al [1996], concluded that long- term home physiotherapy 
with the flutter was effective in COPD in improving airflow, ability & symptoms.44 
                Wolkove N et al [2004], stated that flutter appeared to be equally as 
effective as conventional manual chest therapy (CPT) when used as bronchial 
hygiene therapy for the promotion of sputum mobilization and improved breath 
sounds.46 
               Brooks D et al [2002], demonstrated that there was positive incline and a 
large airflow response in an increase in expiratory procedure with flutter.6 
               Raschi S[1994], et al compared Short term effect of postural drainage 
,flutter & ELTGOL   in acute exacerbation  of chronic bronchitis and concluded 
that all the treatments were safe & effective in removing secretion causing 
undesirable effect on oxygen saturation but flutter & ELTGOL techniques were 
more effective in secretion.5 
               Retzow A, Cegla et al [1993], concluded that flutter in addition to 
promoting mucus expectoration, also improves pulmonary function in patients with 
obstructive lung disease.11 
               Nixon PA et al [1999], demonstrated that patients using the flutter device 
had better pulmonary function after 1 week of therapy and similar improvement in 
pulmonary function & exercise tolerance compared to chest physical therapy after 
2 weeks of treatment, suggesting that flutter valve therapy is an acceptable 
alternative to standing chest physical therapy in hospital care of patients with 
cystic fibrosis.18 
              Balgburm M [1995], found flutter to be 3 times more effective in 
increasing sputum expectoration as traditional drainage & chest clapping.3 
              Pike SE et al [1999], stated that inclusion of the forced expiratory 
maneuver in the regimen would likely to increase the effectiveness of airway 
clearance.30 
               Sahl W et al (1989) compared flutter with the PEP mask, the flutter 
showed a small increase in spirometry values, whereas PEP mask did not, but the 
two techniques were otherwise comparable.12    
 
2.4.2. DIAPHRAGMATIC BREATHING EXERCISE 
      Jennifer A Pryor reported that breathing control is normal tidal 
breathing using lower chest with relaxation of upper chest and shoulder.32 
      Nancy Humberstone and Jan Stephen Tecklin suggested that deep 
breathing exercise is traditionally performed to increase ventilation. It alleviates 
dyspnea and reduces post operative complications.34 
       Carolyn Kisner suggested that deep breathing exercise are designed to 
improve the efficacy of ventilation, reduce the work of breathing and improve gas 
exchange and oxygenation.9 
               Vitacca M ,Ambrosino N,Clini E[1998], concluded that in severe 
obstructive pulmonary disease patients with chronic hypercapnia, deep 
diaphragmatic breathing was associated with improvement of blood gases at the 
expense of a greater inspiratory muscle loading.43 
                Anderson .J.M, Innocenti D.M, said that breathing exercises are useful 
for assisting in the removal of secretions and improving movement of the thoracic 
cage. 
                Craig L.Scanlan said that patients with chronic obstructive pulmonary 
disease, diaphragmatic breathing exercise had been shown to increase the relative 
contribution of this muscle to ventilation from about 40% to about 67%. 
                  Lateral costal breathing exercises increases mobility of the diaphragm 
and increases ventilation to the lung bases.13 
 
2.4.3. COUHING TECHNIQUE: 
                 Jan Stephen Tecklin et al suggested that coughing is very effective in 
removing secretion.34 
                 Susan B O’Sullivan, Thomas J Schmitz et al said that coughing is the 
most common and easiest means of clearing the airway. High intrathoracic 
pressure, such as those generated during coughing, can force the closing of small 
airways in some patients. Coughing allows the patient to remove secretions.36 
               Joanne Watchie et al mentioned the effectiveness of coughing 
techniques as changes in oxygen saturation, improvements in breath sounds, 
increases in expiratory flow rate and reduction in the patient’s level of dyspnea and 
assist in removal of secretions from the airway.22   
               Rossman CM et al [1982], concluded that in cystic fibrosis, cough 
session may be as effective as therapist- administered physiotherapy in removing 
pulmonary secretions. Frequent, vigorous self- directed cough sessions are useful 
as more complex measures for effective bronchial hygiene.33 
 
    
 2.5. PULMONARY FUNCTION TEST 
 Watchie stated that FEV1 and MVV measure pulmonary function and both 
will be reduced in COPD.22 
 2.6. SUMMARY: 
                 The review of literature gives a clear idea about the development of 
airway clearance techniques in COPD. In recent years the effect of many 
techniques like Active cycle of breathing, Autogenic drainage, ELTGOL, Postural 
drainage and other techniques were compared with Flutter in COPD patients. 
There were only limited studies in investigating the short-term effect of flutter in 
COPD. Thus this study is designed to find out the immediate effect of flutter on 
pulmonary function in patients with chronic bronchitis. 
  
 
 
 
 
 
 
 
 
 
3. AIM AND OBJECTIVES 
 
3.1. AIM: 
               To study the immediate effect of flutter device on pulmonary function in 
patients with chronic bronchitis. 
 
3.2. OBJECTIVES: 
1. To find out the immediate effect of conventional physiotherapy on 
pulmonary function in chronic bronchitis patients. 
2. To find out the immediate effect of flutter along with conventional 
physiotherapy on pulmonary function in chronic bronchitis patients. 
3. To improve the pulmonary function. 
 
 
                              
 
 
 
 
 
4. MATERIALS AND METHODOLOGY 
 
4.1. STUDY DESIGN  
          Pre test - post test experimental study design. 
 
4.2. STUDY SETTING 
          Department of Physical Medicine & Rehabilitation, 
          Kovai Medical Center & Hospital, 
          Coimbatore. 
        
4.3. SAMPLE TECHNIQUE 
           Purposive sampling technique 
 
4.4. SAMPLE SIZE 
           30 patients 
           Group A: 15 subjects (conventional physiotherapy) 
           Group B: 15 subjects (flutter along with conventional physiotherapy). 
 
 
  
4.5. SELECTION CRITERIA:   
    4.5.1. Inclusion Criteria  
• Chronic bronchitis patient who are on regular medication. 
• Sex: Males & Females  
• Age: between 40 – 60 years. 
• BMI: 20-25        . 
• FEV1: 50% - 80% predicted. 
 
    4.5.2. Exclusion criteria  
• Patients with restrictive lung disease 
• Asthma 
• Cardiac diseases like cardiac failure, myocardial infarction etc., 
• Neurological deficits 
• Pulmonary Tuberculosis 
• Patients who has undergone recent thoracic & abdominal surgeries. 
• Cystic fibrosis 
• Rib fracture 
• Un- cooperative patient. 
 
 
4.6. HYPOTHESIS 
  4.6.1. NULL HYPOTHESIS 
      H01: There is no significant immediate effect of conventional physiotherapy 
on pulmonary function in chronic bronchitis patients. 
      H02: There is no significant immediate effect of conventional physiotherapy 
along with flutter on pulmonary function in chronic bronchitis patients. 
      H03: There is no significant difference between conventional physiotherapy 
and conventional physiotherapy along with flutter on pulmonary function in 
chronic bronchitis patients. 
 
     4.6.2. ALTERNATE HYPOTHESIS   
      HA1: There is a significant immediate effect of conventional physiotherapy 
on pulmonary function in chronic bronchitis patients. 
      HA2: There is a significant immediate effect of conventional physiotherapy 
along with flutter on pulmonary function in chronic bronchitis patients. 
      HA3: There is a significant difference between conventional physiotherapy 
and conventional physiotherapy along with flutter on pulmonary function in 
chronic bronchitis patients. 
 
 
4.7 . STUDY METHOD 
         PROCEDURE: 
          4.7.1. GROUP A: CONVENTIONAL PHYSIOTHERAPY 
[Diaphragmatic Breathing Exercise, Segmental breathing, coughing technique,] 
 
D        Diaphragmatic breathing exercise: 
        The technique for diaphragmatic breathing exercise is as follows:  
ª The patient should be in a relaxed and comfortable position. 
ª Therapist hand is placed on rectus abdominis just below the anterior costal 
margin. 
ª Patient is asked to breathe in slowly & deeply through the nose with relaxed 
shoulders and patient is asked to hold for 3-5 sec. 
ª Then the patient is asked to place his or her own hand below the anterior 
costal margin and asked to feel the movement.  
ª Patient is advised that the placed hand should rise during inspiration and fall 
during expiration.        
                   Sessions: 1 session / day.   
                   Repetition: 10 repetitions/ session. 
                   Duration: 10-15 min. 
 
  
 
         DIAPHRAGMATIC BREATHING EXERCISE 
 
 
 
 
 
D Segmental breathing:  
Lateral costal expansion: 
ª The patient is positioned in sitting or semi-fowlers position. 
ª The patient is asked to place the hands along the lateral aspect of the lower 
ribs to fix the attention to the areas at which the movement is to occur. 
ª The patient is asked to breathe out to feel the rib cage move downward and 
inward. 
ª Placing the hands over rib area increases sensory awareness as the patient 
breathes into the IRV and the chest expands and ribs flare. 
 
             
                       LATERAL COSTAL EXPANSION EXERCISE 
Posterior basal expansion: 
ª The patient is positioned in sitting and lean forward on a pillow, slightly 
bending the hips. 
ª The patient is asked to perform the same maneuver, by placing hands on 
posterior aspects of lower ribs. 
Repetition: 2 sets of 5 repetitions are given. 
Duration: 10 minutes. 
 
D Coughing technique: 
ª The patient is placed in a relaxed and comfortable position. Sitting or 
forward leaning is usually the best recommended position for coughing. 
ª The patient’s neck is slightly flexed to make coughing more comfortable. 
ª The patient is taught controlled diaphragmatic breathing, emphasizing deep 
inspiration. 
ª A sharp, deep, double cough and the proper muscle action of coughing 
[contraction of the abdominals] are demonstrated. 
ª The patient is instructed to place his/her hands on the abdomen and to make 
three huffs with expiration and feel the contracting abdominals. 
ª The patient is taught to make a ‘k’ sound to experience tightening the vocal 
cords, closing the glottis, and contracting the abdominals. 
ª When the patient has put these actions together, he/she is instructed to take a 
deep but relaxed inspiration, followed by a sharp double cough. In a single 
expiration, the second cough is more productive. 
 
4.7.2. GROUP B: CONVENTIONAL PHYSIOTHERAPY ALONG 
WITH FLUTTER 
ª The patient is asked to sit in a comfortable upright sitting position with        
   elbow support on a table and neck slightly extended in order to open        
   up the airway. 
ª In order to get a maximal oscillatory effort the flutter device is held in the 
mouth horizontally and tilted slightly upwards.   
ª Inspiration is done through the nose. A slow  breath in, slightly deeper than 
normal with a breath hold of 3-5 seconds followed by breath out through the 
flutter device in a slightly faster rate than normal. 
ª After 4-8 of these breaths, a deep breath with a ‘hold’ at full inspiration is 
followed by a forced expiration through the flutter device. This precipitates 
expectoration and is followed by a pause for breathing control, and then 
according to the subjects’ preference a cough or huff is done. 
ª The upward movement of the flutter increases the pressure and frequency, 
while movement of the device downward results in lower pressure and 
frequency. While doing the procedure the patient should keep the cheeks 
flat and use the abdominal muscles to produce effective exhalation.  
ª The vibration of the chest is palpated by the patient to provide feedback as to 
the device. A flutter session lasts 15 minutes.  
ª To avoid dizziness due to hyperventilation, a patient should refrain from 
forced exhalation. It may be necessary to have a pause every 5-10 
exhalations before resuming the session. 
                     Treatment time: 10-15 minutes. 
 
                 
                                 PULMONARY FUNCTION TEST 
 
                 
                                                     FLUTTER 
 
    4.8. MEASUREMENT TOOLS 
• Computerized Pulmonary Function Test was used to find the 
 -Forced Expiratory Volume in 1 second [FEV1] 
 -Maximum voluntary ventilation [MVV]. 
             Outcome measures are measured before and after treatment. 
 
 
4.9. STATISTICAL ANALYSIS 
                   Pre-test and Post-test values of the study are collected and assessed for 
variation in improvement & their results were analyzed using Independent `t’ test 
and Paired `t’ test.  
 
 4.9.1. PAIRED `t’ TEST (within groups) 
 
                                                   t =
ௗത√௡
ௌ
  
               Where, 
                                            S =ට
∑ ࢊ૛ିඃࢊഥඇ
૛
ൈ࢔
࢔ି૚
               
 
 
    4.9.2. INDEPENDENT `t’ TEST (between groups) 
 
                                                  ݐ ൌ ௑ଵതതതതି௑ଶതതതത
ௌ ට
௡భ௡మ
ሺ௡భା௡మሻ
 
                Where,                         
                                                  ܵ ൌ ට
∑ ௗభ
మା∑ ௗమ
మ
௡భା௡మషଶ
      
     
                      S= combined standard deviation 
                ݀ଵ&݀ଶ = difference between initial & final readings in group A &group B  
                  respectively. 
                  ݊ଵ&݊ଶ= number of patients in group A & group B respectively. 
                              ܺ ଵതതതത&ܺଶതതത = Mean of group A & group B respectively. 
                                        Level of significance: 5% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5. DATA PRESENTATION 
 
 
        5.1. TABULAR PRESENTATION: 
 
Paired‘t’ test 
 
Table I: - FEV1 
 
GROUP A 
   
     
 
                  Mean values 
                          [%] 
 
 Pre-test 
 
 
Post-test 
     
    61.22 
   
     64.14 
 
              Calculated ‘t’ value 
 
                   2.69 
 
  p value and level of significance 
 
p < 0.05 and significant 
 
 
 
 
                                              GROUP B 
 
     
 
                  Mean values 
                           [%] 
 
  Pre-test 
 
 
Post-test 
     
    62.92 
   
     67.55 
 
              Calculated ‘t’ value 
 
              3.00 
 
  p value and level of significance 
 
p < 0.05 and significant 
 
 
 
 
 
 
 
 
Table II:- MVV 
 
GROUP A 
 
     
 
                  Mean values 
                          [%] 
 
  Pre-test 
 
 
Post-test 
     
    13.44 
   
     15.6 
 
              Calculated ‘t’ value 
 
              3.83 
 
  p value and level of significance 
 
p < 0.05 and significant 
 
   
 
 
GROUP B 
 
     
 
                  Mean values 
                            [%] 
 
  Pre-test 
 
 
Post-test 
     
    17.51 
   
     20.92 
 
              Calculated ‘t’ value 
 
              3.91 
 
  p value and level of significance 
 
p < 0.05 and significant 
 
 
 
 
 
 
 
 
                                                  
 
 
INDEPENDENT‘t’ TEST 
 
 
 
 
Table III: - FEV1 
 
 
   
    Mean    
Values 
      [%] 
 
Calculated 
  ‘t’ value 
 
p value and level of               
significance 
 
     
    Pre-test 
 
Group A 
 
    61.22 
 
 
       0.47 
 
 
p >0.05 and not significant 
 
Group B 
 
    62.92 
 
 
   Post-test 
 
Group A 
 
   64.14 
 
  
            1 
 
 
p > 0.05 and not significant 
 
Group B 
 
   67.53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table IV:- MVV 
 
 
   
 Mean    
Values 
   [%] 
 
Calculated 
  ‘t’ value 
 
p value and level of        
significance 
 
 
     Pre-test 
 
Group A 
 
    14.24 
 
 
       1.358 
 
 
p > 0.05 and not significant 
 
Group B 
 
    16.07 
 
    Post-test 
 
Group A 
 
   15.46 
 
  
        2.77 
 
 
p < 0.05 and  significant 
 
Group B 
 
   20.9 
 
 
 
 
 
 
 
 
 
   5.2. G
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6. DATA ANALYSIS AND INTERPRETATION 
 
                     The changes within the group were analyzed using paired‘t’ test and 
the difference between the groups were analyzed using independent‘t’ test. 
¾ FEV1 
 Pre-test  
                    When the pre-test values of group A and group B were analyzed by 
independent‘t’ test the calculated‘t’ value is 0.47. The table‘t’ value at 5% level of 
significance for 28 degrees of freedom is 1.711, which is greater than the 
calculated ‘t’ value. Hence no significant difference is found between the groups.  
 Group A 
                    When the pre-test and post-test values were analyzed by paired‘t’ test, 
the calculated‘t’ value is 2.69. For 14 degrees of freedom at 5% level of 
significance the table‘t’ value is 1.761. Since the calculated‘t’ value is greater than 
the table‘t’ value, the null hypothesis is rejected.  
 Group B 
                    When the pre-test and post-test values were analyzed by paired‘t’ test, 
the calculated‘t’ value is 3.00. For 14 degrees of freedom at 5% level of 
significance the table‘t’ value is 1.761. Since the calculated‘t’ value is greater than 
the table‘t’ value, the null hypothesis is rejected. 
  Post-test 
                   The table‘t’ value for 28 degrees of freedom at 5% level of significance 
is 1.711. The values are analyzed by independent‘t’ test. The calculated‘t’ value is 
1.00, which is lesser than the table‘t’ value. Hence no significant difference is 
found between the groups.   
 
¾ MVV 
 Pre-test  
                    When the pre-test values of group A and group B were analyzed by 
independent‘t’ test the calculated‘t’ value is 1.358. The table‘t’ value at 5% level 
of significance for 28 degrees of freedom is 1.711, which is greater than the 
calculated ‘t’ value. Hence no significant difference is found between the groups.  
 Group A 
                    When the pre-test and post-test values were analyzed by paired‘t’ test, 
the calculated‘t’ value is 3.83. For 14 degrees of freedom at 5% level of 
significance the table‘t’ value is 1.761. Since the calculated‘t’ value is greater than 
the table‘t’ value, the null hypothesis is rejected.  
 
s 
 Group B 
                    When the pre-test and post-test values were analyzed by paired‘t’ test, 
the calculated‘t’ value is 3.91. For 14 degrees of freedom at 5% level of 
significance the table‘t’ value is 1.761. Since the calculated‘t’ value is greater than 
the table‘t’ value, the null hypothesis is rejected.  
 Post-test 
                   The table‘t’ value for 28 degrees of freedom at 5% level of significance 
is 1.711. The values are analyzed by independent‘t’ test. The calculated‘t’ value is 
2.77, which is greater than the table‘t’ value. Hence there is significant difference 
between the groups.   
 
                     
 
 
 
 
 
 
 
 
 
 
7. DISCUSSION 
                  Chronic obstructive pulmonary disease pertain to a number of chronic 
pulmonary conditions, all of which obstruct the flow of air in the respiratory tract 
and affect ventilation and gas exchange. It affects the activities of daily living of a 
large proportion of the population.  
              Physiotherapist uses various airway clearance techniques in the 
management of airway secretions.   
              This study was conducted to find the immediate effect of Flutter on 
pulmonary function in chronic bronchitis patients.                                                                           
               In this study, 30 patients with chronic bronchitis were selected and 
divided into 2 groups, each group contains 15 patients. Group A received 
conventional physiotherapy and   group B received Flutter along with conventional 
physiotherapy. 
               Computerized pulmonary function test was used to measure the outcome 
measures. Parameters used for data collection are FEV1 and MVV. 
               The statistical analysis was done using paired‘t’ test and independent‘t’ 
test. 
               The paired‘t’ test analysis showed that there was a statistically significant 
changes within both the groups. 
      The improvement could be due to the effect of diaphragmatic breathing 
exercise, lateral costal expansion and posterior basal expansion & coughing 
technique. The effects are improved efficiency of ventilation, decreased work of 
breathing, increased excursion of the diaphragm, improved gas exchange and 
oxygenation & mobilize lung secretions.8 
                Craig L.Scanlan said that patients with chronic obstructive pulmonary 
disease, diaphragmatic breathing exercise have been shown to increase the relative 
contribution of this muscle to ventilation from about 40% to about 67%. 
                Lateral costal breathing exercises increases mobility of the diaphragm 
and increases ventilation to the lung bases.13 
               Along with this in experimental group, flutter helps in mucus loosening, 
mobilization and elimination which reduces the airway obstruction that leads to 
improvement in pulmonary function.23  
      On statistical analysis using independent‘t’ test between group A and 
group B showed significant difference in MVV. This could be due to the effect of 
flutter as a mucus clearance device is based on its ability, to vibrate the airways, 
intermittently increase endobronchial pressure which helps maintain the patency of 
the airways during exhalation so that mucus does not become trapped as it moves 
up the airways and accelerate expiratory airflow which facilitates the upward 
movement of mucus through the airways so that it can be more easily cleared. 
      On statistical analysis using independent‘t’ test between group A and 
group B showed no significant difference in FEV1. But the mean value of 
experimental group is greater than control group mean. The lack of significance 
might be due to the meager sample size and the shorter duration of study. 
      The result correlates with the study done by Konstan et al, who found a 
large increase in expectorated sputum volume with flutter therapy compared with 
cough or conventional chest physiotherapy.23 
     Bellone A et al (2000) compared the effectiveness of PEP using flutter 
device with postural drainage and ELTGOL, concluded that flutter techniques was 
more effective in secretion removal in chronic bronchitis.4 
     Eaton T et al (2007) suggested that flutter device was well accepted and 
tolerated airway clearance device and the patient preference was more for flutter 
device compared to ACBT & postural drainage.12 
      In contrast, Pryor et al found that significantly more sputum was 
produced with the ACBT than with the flutter in individual supervised sessions in 
patients.31 
     Since flutter device has a significant effect on pulmonary function, it 
could be implemented in clinical practice to improve the pulmonary function in 
COPD patients.  
 
 
8. SUMMARY AND CONCLUSION 
 
   Secretion clearance and improvement of pulmonary function is the primary 
goal in the treatment of COPD patients. Various techniques are used to remove the 
secretions from the lung. 
  In order to find the effectiveness of flutter on pulmonary function, it has 
been conducted with 2 groups, each consists of 15 patients. Group A received 
conventional physiotherapy and group B received flutter along with conventional 
physiotherapy for a single day. Pulmonary function test was done using 
computerized spirometry to measure FEV1 and MVV. Pre-test and post-test was 
taken. The statistical analysis using paired‘t’ test at 5% level of significance 
showed that there is significant improvement in patients of both the groups. 
 But independent‘t’ test at the 5% level of significance showed that there is 
no significant difference in MVV. 
 Based on the outcome results it can be concluded that flutter has immediate 
effect on pulmonary function and it can be used in the treatment of patients with 
COPD. 
 
 
 
 
9. LIMITATIONS AND SUGGESTIONS 
 
1. This study has been done with smaller number of patients. Study with a 
large population is recommended. 
2. The study was a short term study, therefore long term study is 
recommended. 
3. Further studies using combination of airway clearance techniques along 
with flutter, with varying durations and position can be done to obtain 
maximum therapeutically output. 
4. This study only deals with objective measurement. A study which also 
deals with subjective measures such as dyspnea is recommended. 
5. Measurement tools used in the study to measure pulmonary function 
were computerized pulmonary function test [FEV1 & MVV]. Other 
measurements criteria like PEFR, arterial oxygen saturation, respiratory 
rate, heart rate, and sputum volume can also be included. 
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APPENDIX I 
 
 
INFORMED CONSENT TO PARTICIPATE IN THE RESEARCH STUDY 
 
I ____________ voluntarily consent to participate in the research study, 
“IMMEDIATE EFFECT OF FLUTTER ON PULMONARY FUNCTION IN 
CHRONIC BRONCHITIS PATIENTS”- An Experimental Study. 
The researcher has explained me about the research in brief, the risk of 
participation and has answered the questions related to the research to my 
satisfaction. 
  
 
Signature of the applicant:                  Signature of the  researcher: 
 
             
          Signature of the witness: 
 
 
 
 
APPENDIX II 
ASSESSMENT FORM 
 
 
Patient profile 
 Name: 
 Age: 
 Sex: 
 Occupation: 
 Address: 
 Diagnosis: 
 Chief complaints: 
 Present medical history: 
 Personal history: 
 Assessment data: 
 Computerized pulmonary function test: 
  
          
 
 
 
S.No Parameters Pre -test Post -test 
    1. FEV1   
    2. MVV   
